Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luciana Madeira da Silva

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|June 17, 2010
Expansion of the target of rapamycin (TOR) kinase family and function in Leishmania shows that TOR3 is required for acidocalcisome biogenesis and animal infectivityLuciana Madeira da Silva, Stephen M Beverley
Journal of Visualized Experiments : Jove|September 14, 2011
Mutagenesis and analysis of genetic mutations in the GC-rich KISS1 receptor sequence identified in humans with reproductive disordersLuciana Madeira da Silva, Lauren Vandepas, Suzy D C Bianco
Proceedings of the National Academy of Sciences of the United States of America|April 23, 2009
Regulated expression of the Leishmania major surface virulence factor lipophosphoglycan using conditionally destabilized fusion proteinsLuciana Madeira da Silva, Katherine L Owens, Silvane M F Murta, et al.
Current Research in Biotechnology|May 17, 2021
DNA damage measurements within tissue samples with Repair Assisted Damage Detection (RADD)Kevin J Lee, Elise Mann, Luciana Madeira da Silva, et al.
Cancer Research|March 2, 2017
Interplay between Immune Checkpoint Proteins and Cellular MetabolismSangbin Lim, Joshua B Phillips, Luciana Madeira da Silva, et al.
Biology|May 5, 2021
Associations between DNA Damage and PD-L1 Expression in Ovarian Cancer, a Potential Biomarker for Clinical ResponseElise K Mann, Kevin J Lee, Dongquan Chen, et al.
Vaccines|August 28, 2021
Long-Term Follow-Up of Gemogenovatucel-T (Vigil) Survival and Molecular Signals of Immune Response in Recurrent Ovarian CancerRodney P Rocconi, Laura Stanbery, Luciana Madeira da Silva, et al.
Plos One|September 13, 2014
ALDH1A1 maintains ovarian cancer stem cell-like properties by altered regulation of cell cycle checkpoint and DNA repair network signalingErhong Meng, Aparna Mitra, Kaushlendra Tripathi, et al.
Plos Neglected Tropical Diseases|September 3, 2011
The susceptibility of trypanosomatid pathogens to PI3/mTOR kinase inhibitors affords a new opportunity for drug repurposingRosario Diaz-Gonzalez, F Matthew Kuhlmann, Cristina Galan-Rodriguez, et al.
Anti-Cancer Agents in Medicinal Chemistry|September 3, 2024
Novel Celecoxib Derivative, RF26, Blocks Colon Cancer Cell Growth by Inhibiting PDE5, Activating cGMP/PKG Signaling, and Suppressing β-catenin-dependent TranscriptionSara Sigler, Mohammad Abdel-Halim, Reem K Fathalla, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Proceedings of the National Academy of Sciences of the United States of America|June 17, 2010
Expansion of the target of rapamycin (TOR) kinase family and function in Leishmania shows that TOR3 is required for acidocalcisome biogenesis and animal infectivityLuciana Madeira da Silva, Stephen M Beverley
Journal of Visualized Experiments : Jove|September 14, 2011
Mutagenesis and analysis of genetic mutations in the GC-rich KISS1 receptor sequence identified in humans with reproductive disordersLuciana Madeira da Silva, Lauren Vandepas, Suzy D C Bianco
Proceedings of the National Academy of Sciences of the United States of America|April 23, 2009
Regulated expression of the Leishmania major surface virulence factor lipophosphoglycan using conditionally destabilized fusion proteinsLuciana Madeira da Silva, Katherine L Owens, Silvane M F Murta, et al.
Current Research in Biotechnology|May 17, 2021
DNA damage measurements within tissue samples with Repair Assisted Damage Detection (RADD)Kevin J Lee, Elise Mann, Luciana Madeira da Silva, et al.
Cancer Research|March 2, 2017
Interplay between Immune Checkpoint Proteins and Cellular MetabolismSangbin Lim, Joshua B Phillips, Luciana Madeira da Silva, et al.
Biology|May 5, 2021
Associations between DNA Damage and PD-L1 Expression in Ovarian Cancer, a Potential Biomarker for Clinical ResponseElise K Mann, Kevin J Lee, Dongquan Chen, et al.
Vaccines|August 28, 2021
Long-Term Follow-Up of Gemogenovatucel-T (Vigil) Survival and Molecular Signals of Immune Response in Recurrent Ovarian CancerRodney P Rocconi, Laura Stanbery, Luciana Madeira da Silva, et al.
Plos One|September 13, 2014
ALDH1A1 maintains ovarian cancer stem cell-like properties by altered regulation of cell cycle checkpoint and DNA repair network signalingErhong Meng, Aparna Mitra, Kaushlendra Tripathi, et al.
Plos Neglected Tropical Diseases|September 3, 2011
The susceptibility of trypanosomatid pathogens to PI3/mTOR kinase inhibitors affords a new opportunity for drug repurposingRosario Diaz-Gonzalez, F Matthew Kuhlmann, Cristina Galan-Rodriguez, et al.
Anti-Cancer Agents in Medicinal Chemistry|September 3, 2024
Novel Celecoxib Derivative, RF26, Blocks Colon Cancer Cell Growth by Inhibiting PDE5, Activating cGMP/PKG Signaling, and Suppressing β-catenin-dependent TranscriptionSara Sigler, Mohammad Abdel-Halim, Reem K Fathalla, et al.
Pageof 2